Monday, February 24, 2020

Taiwan completes composite class pharmaceutical synthesis of Remdesivir

Ref : https://news.ebc.net.tw/news/living/198698?fbclid=IwAR2ioToNj3JQlaCAE54O_OR_01dtd2zKUVv_SafrnMxVyimKQZrqEFpBR3cWe need 
Summary Translation : Gan Yung Chyan
                                     / KUCINTA SETIA

Image courtesy : Wikipedia

Taiwan has completed premium class pharmaceutical synthesis of Remdesivir, the drug first patented and developed by Gilead Science, as a treatment for COVID-19 (covid, in short). Recently, Taiwan President Tsai Ing Wen completed the declaration, announcing Remdesivir composite class with 97 per cent purity can be promoted and self-produced in Taiwan.

In the near future, a combination of a laboratory and a factory located in Taiwan will be licensed by  the National Academy of Health to engage in a large-scale synthetic production, thus contributing to the  anti-epidemic cooperative efforts on the island. 

Taiwan has 30 confirmed covid cases including one death, as of 25 February 2020.

Further Ref : Remdesivir, Wikipedia
https://en.wikipedia.org/wiki/Remdesivir

https://ncov.dxy.cn/ncovh5/view/pneumonia

No comments:

Post a Comment